col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


37 Results       Page 1

 [1] 
Elsevier: Atherosclerosis
  original article Date Title Authors   All Authors
1 [GO] 2022―Mar―12 Lipoprotein(a) in COVID-19: Genetics and inflammation collide Martina Montagnana, Giuseppe Lippi
2 [GO] 2021―Dec―22 Pre-infection HDL-cholesterol levels and mortality among elderly patients infected with SARS-CoV-2 Jose M. Mostaza, Miguel A. Salinero-Fort, Juan Cardenas-Valladolid, Fernando Rodriguez-Artalejo, Mariana Díaz-Almiron, Pilar Vich-Pérez, et al. (+3)
3 [GO] 2021―Dec―21 Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study Nick S. Nurmohamed, Didier Collard, Laurens F. Reeskamp, Yannick Kaiser, Jeffrey Kroon, Tycho R. Tromp, et al. (+9)
4 [GO] 2021―Nov―13 Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality Michael Feher, Mark Joy, Neil Munro, William Hinton, John Williams, Simon de Lusignan
5 [GO] 2021―Sep―15 Reply to: “Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead” Monica Verdoia, Giuseppe De Luca
6 [GO] 2021―Sep―03 Dynamic of lipoprotein responses in patients with severe COVID-19 A. Leonard, A. Doolan, G. Boran, D. Burke, T. Moulton, M. Donnelly, et al. (+2)
7 [GO] 2021―Sep―03 Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19 O. Ahmed, A.K. Mukarram, C. Pirazzini, E. Elena Marasco, M. Pedrelli, M.E. Minniti, et al. (+8)
8 [GO] 2021―Sep―03 Patients with symptomatic coronary artery disease are at the increased risk of worsening the course of the disease after recovery from COVID-19 A.V. Shalaeva, K.T. Mirakhmedova, A.K. Shadmanov
9 [GO] 2021―Sep―03 SARS-COV-2 (COVID-19) anosmia in patients with obesity: A retrospective study N. Sarantis, M. Vlachopoulou, G. Chatzis
10 [GO] 2021―Sep―03 Retrospective study of patients admitted form March to January 2021 by COVID-19 in hospital Infanta Elena (Huelva). M.E. Mansilla Rodríguez, A. Fulgencio Delgado, G. Mariscal Vázquez, J.I. Ramos Clemente Romero
11 [GO] 2021―Sep―03 presentation of SARS-CoV-2 (COVID-19 in patients with congestive heart failure. A Retrospective study G. Chatzis, M. Vlachopoulou, A.E. Gawish, A.A.A. Alslmy, M.A. Karish, N.K. Aljarbaa, et al. (+10)
12 [GO] 2021―Sep―03 Can plasma lipid levels be correlated to severe COVID-19 infection? O.A. Uyaroğlu, M. Özdede, N. Çalık Başaran, B. Köylü, T.K. Şahin, L. Özışık, et al. (+2)
13 [GO] 2021―Sep―03 COVID-19 pandemic and triggered acute myocardial infarction and out-of-hospital cardiac arrest in non-infected individuals A. Hammoudeh, E. Mdanat, R. Almoheisen, M. Jabari, H. Janabi, R. Ibdah
14 [GO] 2021―Sep―03 How the way we live will look different in the wake of the COVID-19 pandemic? A survey in Greece D.B. Panagiotakos, R. Kosti, C. Vassou, C. Pitsavos
15 [GO] 2021―Sep―03 COVID-19-related quarantine effect on dietary habits in a northern italian rural population: Data from the BRISIGHELLA heart study A.F.G. Cicero, F. Fogacci, M. Giovannini, M. Mezzadri, E. Grandi, C. Borghi
16 [GO] 2021―Sep―03 Statin therapy and COVID-19: A retrospective cohort study in a province of Northern Italy S. Greco, F. Luciani, E. Giorgini, A. D'Amuri, M. Lopreiato, V. Fortunato, et al. (+4)
17 [GO] 2021―Sep―03 Diabetes and overweight/obesity are independent, non-additive, risk factors for the in-hospital severity of COVID-19: An international, multi-center retrospective analysis D.K. Longmore, J.E. Miller, S. Bekkering, C. Saner, E. Mifsud, Y. Zhu, et al. (+5)
18 [GO] 2021―Sep―03 Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection. I. Rossi, D. D'Ardes, B. Bucciarelli, M. Allegra, M.T. Guagnano, F. Santilli, et al. (+5)
19 [GO] 2021―Sep―03 Development features of coronavirus disease complications in patients with coronary heart disease N.M. Nurillaeva, M.M. Makhkamova, K.B. Omarov
20 [GO] 2021―Sep―03 Creation of a transgenic mouse model to study the SARS-CoV-2 effect on the pathogenesis of atherosclerosis M. Kubekina, L. Ilchuk, A. Bruter, A. Deykin
21 [GO] 2021―Sep―03 Acute myocardial infarction after laboratory confirmed SARS-CoV-2 infection J. Ena, M. Bou-Collado, M.D. Reyes-Jara, R. Afonso-Carrillo, R. Mulet, V. Valls
22 [GO] 2021―Sep―03 SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 S. Pagano, S. Yery, B. Meyer, C. Juillard, N. Suh, C. Le Terrier, et al. (+15)
23 [GO] 2021―Sep―03 How controlled were dyslipidemias in a year of pandemic? E.M.M. Silva, B. Marques, C. Cunha, R. Ferreira, C. Bello, C. Limbert, et al. (+2)
24 [GO] 2021―Aug―12 Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
25 [GO] 2021―Jul―21 Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry Giuseppe De Luca, Niels Debel, Miha Cercek, Lisette Okkels Jensen, Marija Vavlukis, Lucian Calmac, et al. (+75)
26 [GO] 2021―Jun―25 Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis Anastasios Kollias, Konstantinos G. Kyriakoulis, Ioannis G. Kyriakoulis, Thomas Nitsotolis, Garyphallia Poulakou, George S. Stergiou, Konstantinos Syrigos
27 [GO] 2021―May―27 Teaching an old dog new tricks: The prognostic role of CACS in hospitalized COVID-19 patients Ahmed Ibrahim Ahmed, Paolo Raggi, Mouaz H. Al-Mallah
28 [GO] 2021―Apr―17 The prognostic role of cardiac troponin in hospitalized COVID-19 patients Ibrahim Halil Tanboğa, Uğur Canpolat, Elif Hande Özcan Çetin, Harun Kundi, Sema Turan, Osman Celik, et al. (+5)
29 [GO] 2021―Apr―07 Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 Alessandra Scoccia, Guglielmo Gallone, Alberto Cereda, Anna Palmisano, Davide Vignale, Riccardo Leone, et al. (+32)
30 [GO] 2021―Feb―15 Coronavirus disease-19: The multi-level, multi-faceted vasculopathy Thiago Quinaglia, Mahsima Shabani, Ikaro Breder, Harry A. Silber, João A.C. Lima, Andrei C. Sposito
31 [GO] 2021―Jan―24 Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment Alpo Vuorio, Frederick Raal, Markku Kaste, Petri T. Kovanen
32 [GO] 2020―Dec―23 Patient referrals audit: Evaluation of local cardiovascular risk clinic referrals to help aid patient triage during COVID-19 A.H. Boal, C.M. Ross
33 [GO] 2020―Dec―23 Obesity is a major risk factor for severe COVID-19 illness H.L. Li, B.M. Cheung
34 [GO] 2020―Oct―14 Endothelial dysfunction in COVID-19: Current findings and therapeutic implications Matthias P. Nägele, Bernhard Haubner, Felix C. Tanner, Frank Ruschitzka, Andreas J. Flammer
35 [GO] 2020―Sep―15 Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK Zohaib Iqbal, Jan Hoong Ho, Safwaan Adam, Michael France, Akheel Syed, Dermot Neely, et al. (+15)
36 [GO] 2020―Jun―16 Management of acute myocardial injury in patients with confirmed or suspected COVID-19 Yiannis S. Chatzizisis, Ganesh Gajanan, Deepak L. Bhatt, George Dangas, Thomas Porter
37 [GO] 2020―May―28 SARS-CoV-2 as a protective factor for cardiovascular mortality? Frédéric Dutheil, Marion Trousselard, Valentin Navel
 [1] 

37 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec